← Back to Patent Explorer
US4062966A Expired / Lapsed US ⏱️ 0.0 years remaining

1-Aryl-2-(1-imidazolyl) alkyl ethers and thioethers

Assignee: Pfizer Inc
•
Filing: 1976-04-12
•
Granted: 1977-12-13
•
Expires: 1996-04-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel 1-aryl-2-(1-imidazolyl)alkyl ethers and thioethers having anti-fungal properties are disclosed.

Inventors

  • 👤 Geoffrey E. Gymer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 11:27
CPC Classifications
C; C07; C07D; C07D231/00; C07D231/02; C07D231/10; C07D231/12; A; A61; A61P; A61P31/00; A61P31/04; C07D233/00; C07D233/54; C07D233/56; C07D249/00; C07D249/02; C07D249/08

Claims Analysis

Total Claims: 27
Claim 1
Independent Claim 109 words
A 1-aryl-2-(1-imidazolyl)alkyl ether or thioether having the formula: ##STR12## and the pharmaceutically acceptable acid addition salts thereof wherein R 1 , R 2 , R 3 and R 4 are each hydrogen or alkyl of from 1 to 6 carbon atoms; Ar is phenyl, substituted phenyl, said substituents being halogen, alkyl of from 1 to 6 carbon atoms or alkoxy of from 1 to 6 carbon atoms, thienyl or halothienyl; Z is oxygen or sulfur; n is 1 or 2; and Y is thienyl or substituted thienyl group, said substituents being halogen, alkyl of from 1 to 6 carbon atoms or alkoxy of from 1 to 6 carbon atoms.
Claim 2
Dependent Claim 109 words
A 1-aryl-2-(1-imidazolyl)alkyl ether or thioether having the formula: ##STR12## and the pharmaceutically acceptable acid addition salts thereof wherein R 1 , R 2 , R 3 and R 4 are each hydrogen or alkyl of from 1 to 6 carbon atoms; Ar is phenyl, substituted phenyl, said substituents being halogen, alkyl of from 1 to 6 carbon atoms or alkoxy of from 1 to 6 carbon atoms, thienyl or halothienyl; Z is oxygen or sulfur; n is 1 or 2; and Y is thienyl or substituted thienyl group, said substituents being halogen, alkyl of from 1 to 6 carbon atoms or alkoxy of from 1 to 6 carbon atoms.
Claim 3
Dependent Claim 15 words
A compound as claimed in claim 1 in which Ar is phenyl or substituted phenyl.
Claim 4
Dependent Claim 12 words
A compound as claimed in claim 1 in which Z is oxygen.
Claim 5
Dependent Claim 12 words
A compound as claimed in claim 1 in which Z is sulfur.
Claim 6
Dependent Claim 25 words
A compound as claimed in claim 1 in which R 1 , R 2 , R 3 and R 4 are each a hydrogen atom.
Claim 7
Dependent Claim 14 words
A compound as claimed in claim 2 in which Ar is a 2,4-dichlorophenyl group.
Claim 8
Dependent Claim 12 words
A compound as claimed in claim 1 in which n is 1.
Claim 9
Dependent Claim 16 words
A compound as claimed in claim 1 in which Y is a thienyl or halothienyl group.
Claim 10
Dependent Claim 1 words
1-[2,4-dichloro-β-(3-thienylmethoxy)phenethyl]imidazole.
Claim 11
Dependent Claim 1 words
1-[2,4-dichloro-β-(3-thienylmethoxy)phenethyl]imidazole.
Claim 12
Dependent Claim 1 words
1-[2,4-dichloro-β-(5-chloro-2-thienylmethoxy)phenethyl]imidazole.
Claim 13
Dependent Claim 1 words
1-[2,4-dichloro-β-(5-chloro-2-thienylmethoxy)phenethyl]imidazole.
Claim 14
Dependent Claim 1 words
1-[2,4-dichloro-β-(2-chloro-3-thienylmethoxy)phenethyl]imidazole.
Claim 15
Dependent Claim 1 words
1-[2,4-dichloro-β-(2-chloro-3-thienylmethoxy)phenethyl]imidazole.
Claim 16
Dependent Claim 1 words
1-[2,4-dichloro-β-(2-thienylmethoxy)phenethyl]imidazole.
Claim 17
Dependent Claim 1 words
1-[2,4-dichloro-β-(2-thienylmethoxy)phenethyl]imidazole.
Claim 18
Dependent Claim 1 words
1-[2,4-dichloro-β-(2,5-dichloro-3-thienylmethoxy)phenethyl]imidazole.
Claim 19
Dependent Claim 1 words
1-[2,4-dichloro-β-(2,5-dichloro-3-thienylmethoxy)phenethyl]imidazole.
Claim 20
Dependent Claim 1 words
1-[2,4-dichloro-β-(5-chloro-2-thienylmethylthio)phenethyl]imidazole.
Claim 21
Dependent Claim 1 words
1-[2,4-dichloro-β-(5-chloro-2-thienylmethylthio)phenethyl]imidazole.
Claim 22
Dependent Claim 1 words
1-[2,4-dichloro-β-(3-thienylmethylthio)phenethyl]imidazole.
Claim 23
Dependent Claim 1 words
1-[2,4-dichloro-β-(3-thienylmethylthio)phenethyl]imidazole.
Claim 24
Dependent Claim 2 words
1-[2-(5-chloro-2-thienyl)-2-(3-chloro-2-thienylmethoxy)ethyl] imidazole.
Claim 25
Dependent Claim 2 words
1-[2-(5-chloro-2-thienyl)-2-(3-chloro-2-thienylmethoxy)ethyl] imidazole.
Claim 26
Dependent Claim 34 words
A composition in dosage unit form useful for the treatment of fungal infections comprising a pharmaceutical carrier containing from about 10 mg. to about 3,000 mg. of a compound as claimed in claim 1.
Claim 27
Dependent Claim 34 words
A method of treating fungal infections in animals which comprises parentally or orally administering to an animal in need of such treatment an antifungal effective amount of a compound as claimed in claim 1.

References Cited (Backward Citations)

US3354173A Cited
US3575999A Cited
US3717655A Cited
US3732242A Cited
US3658813A Cited
US3790594A Cited
US3984426A Cited
US3992397A Cited
US3991202A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-12-12 1981-06-13 1981-12-13 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-12-12 1985-06-13 1985-12-13 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-12-12 1989-06-13 1989-12-13 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag